These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35347588)

  • 1. CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251.
    Hucke FIL; Bestehorn-Willmann M; Bassetto M; Brancale A; Zanetta P; Bugert JJ
    Virus Genes; 2022 Jun; 58(3):188-202. PubMed ID: 35347588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and Promising Antivirals Against Chikungunya Virus.
    Hucke FIL; Bugert JJ
    Front Public Health; 2020; 8():618624. PubMed ID: 33384981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
    Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
    Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
    Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
    Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tyrphostin AG879 and A9 inhibiting replication of chikungunya virus by screening of a kinase inhibitor library.
    He Y; Pan Z; Liu Y; Jiang L; Peng H; Zhao P; Qi Z; Liu Y; Tang H
    Virology; 2023 Nov; 588():109900. PubMed ID: 37832343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors.
    Marlina S; Shu MH; AbuBakar S; Zandi K
    Parasit Vectors; 2015 Nov; 8():579. PubMed ID: 26553263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility & replication potential of Vero E6, BHK-21, RD, A-549, C6/36 cells &
    Sudeep AB; Vyas PB; Parashar D; Shil P
    Indian J Med Res; 2019 Jun; 149(6):771-777. PubMed ID: 31496530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic strategies to control chikungunya virus infection.
    Hucke FIL; Bestehorn-Willmann M; Bugert JJ
    Virus Genes; 2021 Apr; 57(2):133-150. PubMed ID: 33590406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
    Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
    J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
    Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG
    Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
    Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
    BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
    Dutta SK; Sengupta S; Tripathi A
    In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
    Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.